The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands
| Year of publication: |
2024
|
|---|---|
| Authors: | Pilz, Micha J. ; Seyringer, Simon ; Hallsson, Lára R. ; Bottomley, Andrew ; Jansen, Femke ; King, Madeleine T. ; Norman, Richard ; Rutten, Marianne J. ; Verdonck-de Leeuw, Irma M. ; Siersema, Peter D. ; Gamper, Eva Maria |
| Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 25.2024, 9, p. 1539-1555
|
| Subject: | Cancer-specific preference-based measure | EORTC QLU-C10D | EQ-5D-3L | Responsiveness | Validity | Niederlande | Netherlands | Messung | Measurement | Kosten-Nutzen-Analyse | Cost-benefit analysis | Gesundheit | Health |
-
Cancer-specific utility : clinical validation of the EORTC QLU-C10D in patients with glioblastoma
Seyringer, Simone, (2025)
-
Stolz, Maike, (2023)
-
Grochtdreis, Thomas, (2023)
- More ...
-
Cancer-specific utility : clinical validation of the EORTC QLU-C10D in patients with glioblastoma
Seyringer, Simone, (2025)
-
U.K. utility weights for the EORTC QLU-C10D
Norman, Richard, (2019)
-
AN AUSTRALIAN DISCRETE CHOICE EXPERIMENT TO VALUE EQ‐5D HEALTH STATES
Viney, Rosalie, (2014)
- More ...